BCM
SGRY icon

Bayesian Capital Management’s Surgery Partners SGRY Stock Holding History

Bayesian Capital Management’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,776
Closed -$588K – 837
2025
Q1 		$588K Buy
+24,776
New +$586K 0.1% 267
2024
Q3 		– Sell
-14,130
Closed -$336K – 1007
2024
Q2 		$336K Buy
+14,130
New +$363K 0.04% 480
2024
Q1 		– Sell
-7,386
Closed -$236K – 1087
2023
Q4 		$236K Buy
+7,386
New +$214K 0.03% 560
2022
Q3 		– Sell
-13,800
Closed -$399K – 988
2022
Q2 		$399K Buy
+13,800
New +$603K 0.07% 395

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bayesian Capital Management's SGRY Position: Q2 2025 in Review

Bayesian Capital Management sold out of Surgery Partners (SGRY) in Q2 2025, closing a stake of 24,776 shares — an estimated $588K sold.

Bayesian Capital Management first reported a position in SGRY in Q2 2022 and held it in 4 quarters. The position peaked at $588K in Q1 2025. 201 funds tracked by Wall St. Rank hold SGRY as of Q2 2025.

  • Bayesian Capital Management reported no remaining Surgery Partners position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 24,776 Surgery Partners shares in Q2 2025, an estimated $588K.
  • Bayesian Capital Management first reported a position in Surgery Partners in Q2 2022 and held it in 4 quarters.
  • Bayesian Capital Management's Surgery Partners position peaked at $588K in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.